Eric Aboagye is Professor of Cancer Pharmacology & Molecular Imaging and Director of the CRUK-EPSRC-MRC-NIHR Comprehensive Cancer Imaging Centre. He joined the college after a PhD at the CRUK Beatson Laboratories in Glasgow, UK and post-doc fellowship at The Johns Hopkins University & Hospital in Baltimore, USA. His group is interested in the discovery and development of new methods for experimental and clinical cancer molecular imaging. In the past 5 years, the team has invented and translated three novel cancer diagnostics into human application. He has acted as an advisor to GE-Healthcare, GSK, Roche and Novartis.
Professor Aboagye was recipient of the 2009 Sir Mackenzie Davidson Medal and was elected as a Fellow of the Academy of Medical Sciences in 2010. Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge or for conspicuous service to healthcare.
et al., 2021, Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC), British Journal of Cancer, ISSN:0007-0920
et al., 2021, Snapshot imprinting: Rapid identification of cancer cell surface proteins and epitopes using molecularly imprinted polymers, Nano Today: an International Rapid Reviews Journal, Vol:41, ISSN:1748-0132, Pages:1-8
et al., 2021, The application of radiomics in laryngeal cancer, British Journal of Radiology, Vol:94, ISSN:0007-1285
et al., 2021, A kit-based aluminium-[F-18]fluoride approach to radiolabelled microbubbles, Chemical Communications, Vol:57, ISSN:1359-7345, Pages:11677-11680
et al., 2021, Consideration of metabolite efflux in radiolabelled choline kinetics, Pharmaceutics, Vol:13, ISSN:1999-4923, Pages:1-18